Drug Type Small molecule drug |
Synonyms |
Target |
Action antagonists |
Mechanism ETA antagonists(Endothelin receptor type A antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic Kidney Diseases | Phase 2 | China | 26 Dec 2024 | |
Essential Hypertension | Phase 2 | China | 26 Sep 2024 | |
Glomerulonephritis, IGA | Phase 1 | China | 19 Jul 2024 |